Literature DB >> 24323987

Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.

Patrizia Ferroni1, Silvia Riondino, Fiorella Guadagni, Mario Roselli.   

Abstract

Entities:  

Keywords:  disease stage; hemostatic activation; venous thromboembolism

Mesh：

Year:  2013        PMID： 24323987      PMCID： PMC3856977          DOI： 10.3324/haematol.2013.092528

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.

Authors:  Melina Verso; Giancarlo Agnelli; Sandro Barni; Giampietro Gasparini; Roberto LaBianca
Journal:  Intern Emerg Med       Date:  2012-05-01       Impact factor: 3.397

2.  Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.

Authors:  Patrizia Ferroni; Francesca Martini; Ilaria Portarena; Gioia Massimiani; Silvia Riondino; Francesca La Farina; Sabrina Mariotti; Fiorella Guadagni; Mario Roselli
Journal:  Clin Lung Cancer       Date:  2012-05-15       Impact factor: 4.785

3.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Authors:  Helen K Chew; Theodore Wun; Danielle Harvey; Hong Zhou; Richard H White
Journal:  Arch Intern Med       Date:  2006-02-27

Review 4.  Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans.

Authors:  Janusz Rak; Joanne L Yu; James Luyendyk; Nigel Mackman
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

Review 5.  Chemotherapy-induced thrombosis.

Authors:  Tufia C Haddad; Edward W Greeno
Journal:  Thromb Res       Date:  2006-01-04       Impact factor: 3.944

6.  Malignancies, prothrombotic mutations, and the risk of venous thrombosis.

Authors:  Jeanet W Blom; Carine J M Doggen; Susanne Osanto; Frits R Rosendaal
Journal:  JAMA       Date:  2005-02-09       Impact factor: 56.272

7.  Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.

Authors:  Boris Dickmann; Jonas Ahlbrecht; Cihan Ay; Daniela Dunkler; Johannes Thaler; Werner Scheithauer; Peter Quehenberger; Christoph Zielinski; Ingrid Pabinger
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

8.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

9.  Soluble CD40 ligand plasma levels in lung cancer.

Authors:  Mario Roselli; Tommaso C Mineo; Stefania Basili; Francesca Martini; Sabrina Mariotti; Simona Aloe; Girolamo Del Monte; Vincenzo Ambrogi; Antonella Spila; Raffaele Palmirotta; Roberta D'Alessandro; Giovanni Davì; Fiorella Guadagni; Patrizia Ferroni
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

10.  Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.

Authors:  Mario Roselli; Patrizia Ferroni; Silvia Riondino; Sabrina Mariotti; Anastasia Laudisi; Matteo Vergati; Francesco Cavaliere; Raffaele Palmirotta; Fiorella Guadagni
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.